Transformational $10 Million Gift to Advance Cancer Research at Tampa General Hospital

Tampa General Hospital Secures $10 Million for Cancer Innovation

In a groundbreaking announcement, the Tampa General Hospital (TGH) Foundation has revealed a monumental gift of $10 million, dedicated to creating an advanced immunotherapy lab. This initiative, named after donors Ian and Jean MacKechnie, aims to significantly enhance cancer research and treatment methodologies at the TGH Cancer Institute.

The rewarding gift will finance the establishment of the Ian & Jean MacKechnie Immunotherapy Lab, which will be strategically located in the USF Health building in downtown Tampa. This facility will play a pivotal role in the Tampa Medical Research District, collaborating closely with the University of South Florida, a partnership that signifies a new horizon in academic research and medical advancements.

The MacKechnies' motivation to contribute arose from Ian MacKechnie's personal experience with cancer treatment at TGH, under the care of Dr. Jorge Marcet, the medical director of Colorectal Surgery Services. Reflecting on his journey, MacKechnie noted, "The care I received was phenomenal; it was delivered with humanity and kindness. It's crucial for us to support TGH as a way to give back and ensure that high-quality care is accessible to our local communities."

This state-of-the-art facility, spanning 8,000 square feet, will become a cornerstone in advancing the science and application of immunotherapies. Dr. Marcet emphasized that this transformative gift strengthens the existing program at the Susan & John Sykes Center of Excellence in Colorectal Cancer, which has already established itself as a hub for immunotherapy innovation. "This investment in research will redefine the future of cancer care by fostering precision-targeted therapies and bringing together top-tier investigators aiming to revolutionize treatment options for patients," he added.

The TGH Cancer Institute is already recognized for its robust immunotherapy program, having recently achieved prestigious FACT accreditation, which underscores its commitment to clinical excellence, innovation, and patient safety in cellular therapies. This accreditation highlights that TGH meets internationally established standards in patient care and related practices, a testament to its dedication to leading-edge medicine.

Dr. Ivan Borrello, a hematologist oncologist and the medical director of the Myeloma, Bone Marrow Transplant, and Cell Therapies program at TGH, expressed gratitude for the generous donation. "This gift lays the groundwork for new innovations in cellular therapies and research that could potentially transform treatment options for cancer patients, reinforcing our commitment to advancing medical science."

Frann Leppla, executive vice president and president of the TGH Foundation, remarked on the profound impact that philanthropic efforts can have when combined with the mission of academic medicine. "The extraordinary generosity of Ian and Jean MacKechnie reflects their commitment to ensuring future excellence in community healthcare, which will uplift and heal countless lives."

Tampa General Hospital stands out as the only academic health system in the Tampa Bay area, providing world-class care that reaches across Florida. With a commitment to the most advanced treatment methodologies and a focus on developing its team extensively, TGH has earned top rankings across multiple healthcare fields. It serves as a safety-net hospital, dedicated to providing care regardless of one’s ability to pay, embodying a model of community health service with an impressive net community benefit to vulnerable populations.

The new immunotherapy lab, along with the ongoing construction of the Taneja Surgical, Neuroscience & Transplant Tower, marks a significant step forward in TGH's journey towards seamless integration of cutting-edge research and patient care. As part of its larger goal to elevate treatment standards, this initiative is anticipated to attract renowned experts in the field, driving further innovations that could benefit countless patients battling life-threatening diseases.

For more information about Tampa General Hospital and its initiatives, visit www.tgh.org.